These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents. Good TJ; Kimura AE; Mandava N; Kahook MY Br J Ophthalmol; 2011 Aug; 95(8):1111-4. PubMed ID: 20702430 [TBL] [Abstract][Full Text] [Related]
6. The effects of intravitreal injections on intraocular pressure and retinal nerve fiber layer: a systematic review and meta-analysis. de Vries VA; Bassil FL; Ramdas WD Sci Rep; 2020 Aug; 10(1):13248. PubMed ID: 32764619 [TBL] [Abstract][Full Text] [Related]
7. Rates of RNFL Thinning in Patients with Suspected or Confirmed Glaucoma Receiving Unilateral Intravitreal Injections for Exudative AMD. Swaminathan SS; Kunkler AL; Quan AV; Medert CM; Vanner EA; Feuer W; Chang TC Am J Ophthalmol; 2021 Jun; 226():206-216. PubMed ID: 33359714 [TBL] [Abstract][Full Text] [Related]
8. Rate of intraoperative complications during cataract surgery following intravitreal injections. Hahn P; Jiramongkolchai K; Stinnett S; Daluvoy M; Kim T Eye (Lond); 2016 Aug; 30(8):1101-9. PubMed ID: 27229705 [TBL] [Abstract][Full Text] [Related]
9. The link between intravitreal antivascular endothelial growth factor injections and glaucoma. SooHoo JR; Seibold LK; Kahook MY Curr Opin Ophthalmol; 2014 Mar; 25(2):127-33. PubMed ID: 24406814 [TBL] [Abstract][Full Text] [Related]
10. Effects of Intravitreal Anti-VEGF Therapy on Glaucoma-like Progression in Susceptible Eyes. Du J; Patrie JT; Prum BE; Netland PA; Shildkrot YE J Glaucoma; 2019 Dec; 28(12):1035-1040. PubMed ID: 31633617 [TBL] [Abstract][Full Text] [Related]
11. "Glaucomatous fields" after monthly intravitreal injections: Normal tension glaucoma or a mimicker? Shah SM; Khanna CL; Yamanuha J; Bakri SJ Am J Ophthalmol Case Rep; 2020 Dec; 20():100904. PubMed ID: 32964169 [TBL] [Abstract][Full Text] [Related]
12. The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology. Hoguet A; Chen PP; Junk AK; Mruthyunjaya P; Nouri-Mahdavi K; Radhakrishnan S; Takusagawa HL; Chen TC Ophthalmology; 2019 Apr; 126(4):611-622. PubMed ID: 30472176 [TBL] [Abstract][Full Text] [Related]
13. Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Shah SM; Boopathiraj N; Starr MR; Dalvin LA; AbouChehade J; Damento G; Garcia MD; Hodge DO; Bakri SJ; Sit AJ; Iezzi R Am J Ophthalmol; 2022 Nov; 243():98-108. PubMed ID: 35932820 [TBL] [Abstract][Full Text] [Related]
14. Short-term intraocular pressure trends following intravitreal ranibizumab injections for neovascular age-related macular degeneration-the role of oral acetazolamide in protecting glaucoma patients. Murray CD; Wood D; Allgar V; Walters G; Gale RP Eye (Lond); 2014 Oct; 28(10):1218-22. PubMed ID: 25081290 [TBL] [Abstract][Full Text] [Related]
15. Effects of Postoperative Intravitreal Injections on Outcomes of Traditional Glaucoma Surgery in Patients with Preoperative Intravitreal Injections. Chang EK; Gupta S; Hall N; Neeson CE; Chang TC; Solá-Del Valle DA Ophthalmol Glaucoma; 2022; 5(2):219-228. PubMed ID: 34500121 [TBL] [Abstract][Full Text] [Related]
16. [Late and sustained intraocular pressure elevation related to intravitreal anti-VEGF injections: Cases requiring filtering surgery (French translation of the article)]. Leleu I; Penaud B; Blumen-Ohana E; Rodallec T; Adam R; Laplace O; Akesbi J; Nordmann JP J Fr Ophtalmol; 2018 Nov; 41(9):789-801. PubMed ID: 30348599 [TBL] [Abstract][Full Text] [Related]
18. Effect of diode laser trans-scleral cyclophotocoagulation in the management of glaucoma after intravitreal silicone oil injection for complicated retinal detachments. Han SK; Park KH; Kim DM; Chang BL Br J Ophthalmol; 1999 Jun; 83(6):713-7. PubMed ID: 10340982 [TBL] [Abstract][Full Text] [Related]
19. The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review. Bracha P; Moore NA; Ciulla TA; WuDunn D; Cantor LB Surv Ophthalmol; 2018; 63(3):281-295. PubMed ID: 28882597 [TBL] [Abstract][Full Text] [Related]
20. Repeated intravitreal anti-vascular endothelial growth factor injections can induce iatrogenic ocular hypertension, especially in patients with open-angle glaucoma. Agard E; Elchehab H; Ract-Madoux G; Russo A; Lagenaite C; Dot C Can J Ophthalmol; 2015 Apr; 50(2):127-31. PubMed ID: 25863852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]